-
Here's why we sold off Apple and McDonald's
Apple appeared to be stalling at the $600 level after climbing to this level in an almost vertical chart move.
Manager Commentary Robert Freedland on 12 Apr 2012
-
Why we added biotech stock Sequenom to the lineup
Sequenom appreciated 11.2% contributing a great deal to the portfolio's performance.
Manager Commentary Robert Freedland on 12 Apr 2012
-
Costco still looks reasonably priced despite advance
It's a hugely important stock to a lot of investors. Is it time to take some profits on Costco?
Manager Commentary Robert Freedland on 29 Mar 2012
-
Riding Herd Over My Model's Lineup Yields Gains
The Buy and Hold model had a good month in February maintaining a slight edge over the S&P 500 index for the month.
Manager Commentary Robert Freedland on 15 Mar 2012
-
Three healthcare stocks I'm buying: Mako, ResMed and Centene
Mako should benefit from the robotic surgical approach in the Orthopedic field.
Manager Commentary Robert Freedland on 13 Feb 2012
-
Dealing with volatility in my Buy & Hold model
I will try to reduce the portfolio turnover and trading frequency in this model in 2012 by staying focused on longer-term performance.
Manager Commentary Robert Freedland on 17 Jan 2012
-
Healthcare investing in an election year
2011 was a challenging year for investors, and for the Healthcare model it was particularly difficult.
Manager Commentary Robert Freedland on 12 Jan 2012
-
Why I bought Genesco
The retailer has been growing both earnings and revenue nicely, exceeding analysts' expectations as well as raising guidance.
Manager Commentary Robert Freedland on 11 Nov 2011
-
Looking to sell Amazon following its earnings report (AMZN)
While long-term I am bullish about the company's prospects, short-term I am less optimistic and shall be looking to exit my position.
Positions Robert Freedland on 27 Oct 2011
-
These companies show fundamental and technical strength
PetSmart (PETM) remains strong as Americans resist cutting back their purchases for Fido during any recession.
Manager Commentary Robert Freedland on 12 Oct 2011
Call 1.866.825.3005 for more information




Follow us